SOL Partnership Sdn Bhd
Our journey began with a commitment to empower individuals with
comprehensive healthcare solutions, challenging the norms of how health is
perceived, addressed, and nurtured.
About Us
Through strategic collaborations and innovative initiatives, SOL Partnership
endeavours to pioneer new frontiers in integrative healthcare, introducing ground-
breaking medical technologies to a diverse array of healthcare stakeholders to
elevate patient care standards in Malaysia and beyond. With a steadfast focus on
fostering B2B relationships, SOL Partnership is dedicated to amplifying the reach
and impact of SOL's transformative healthcare solutions to the healthcare communityin Malaysia.
SOL Partnership Sdn Bhd is the exclusive sole distributor of RGCC Cancer Test &
Therapies in Malaysia. Founded in 2004 by Dr. Ioannis Papasotiriou, RGCC leads
the way in personalised cancer treatment through patient genetics. Our state-of-the-
art tests meticulously analyse genetics, physiology, and immune profiles, enabling
the creation of tailored treatment plans. Operating with cutting-edge technology, our
European labs ensure swift and precise results, empowering medical professionals
to make informed decisions.
Company
Address
6th Floor, Lot 442,
Wisma Hrih Lotus,
Jalan Pahang,
53000 Setapak
Kuala Lumpur.
Phone
Email / Website
Our Featured Products
SOL Partnership
SOL Partnership program is designed to provide doctors with a lucrative
opportunity to practice integrative and holistic healthcare within SOL’s well-
established facility, having access to our equipment and resources to provide
patient care. It allows you to expand your services, increase income potential,
and offer comprehensive care to your patients without the burden of upfront
capital costs.
Link: www.sol.com.my
RGCC Cancer Tests and Therapies
RGCC cancer tests offer promising opportunities for early cancer detection
and treatment. In this process, the focus is always on providing doctors and
patients with a clinical basis on which they can make well-founded and
personalised decisions for individual cancer treatment and therapy. Since
2004, the RGCC team of scientists has been utilising world-leading
technology, and innovative techniques to provide personalised, accessible,
diagnostic, and therapeutic options to patients worldwide.
Link: https://rgcc-international.com/tests/